Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name ACTINOGEN MEDICAL LIMITED Announcement Type New announcement Date of this announcement Tuesday July 28, 2026 The +securities to be quoted are:...
Application for quotation of securities - ACW
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Xanamem depression trial published in British J Psychiatry
- ACW third positive XanaMIA trial data committee review
- Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program
- Actinogen receives positive scientific advice from EMA
- Correction-March2026 quarterly activity report & Appendix 4C
Later from Actinogen Medical
- June 2026 Quarterly activity report & Appendix 4C
- ACW webinar on the future of Alzheimers treatment
- ACW Bioshares presentation, strong cortisol rationale
- Notification of cessation of securities - ACW
- Updated Securities Trading Policy
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical